chromatography was carried out using Merck silica gel (0.040-0.063). Pent-4-ynoic acid (0.9 g, 9.18 mmol) was dissolved in thionyl chloride (3.0 ml). The solution was heated at reflux for 2 hrs before all the solvent was removed under reduced pressure. The desired residue was added slowly into the solution of salicylic acid (633 mg, 4.6 mmol) in pyridine (15 ml) at 0 o C. The mixture was stirred for 30 min at the same temperature and then quenched with ice. EA (200 ml) and HCl aqueous solution (1 N, 100 ml) were subsequently added to reaction mixture. The organics was taken, washed further with HCl aqueous solution (1 N, 100 ml×2) and brine (100 ml), dried over sodium sulfite, filtrated and concentrated, purified with chromatography (Hex/EA = 20/1-5/1) to give Asp-1 (290 mg, 28.8%).
H NMR (500
MHz, CDCl 3 ) δ 8.13 (d, J = 7.5 Hz, 1H), 7.63 (t, J = 7.5 Hz, 1H), 7.36 (t, J = 7.5 Hz, 1H), 7.16 (d, J = 7.5 Hz, 1H), 2.89 (t, J = 7.5 Hz, 2H), 2.67 (td, J 1 = 2.5 Hz, J 2 = 7.5
Hz, 2H), 2.04 (t, J = 2.5 Hz, 1H);
13
C NMR (125 MHz, CDCl 3 ) δ 170. 4, 169.3, 151.0, 134.9, 132.5, 126.2, 124.0, 122.0, 82.2, 69.3, 33.4, 14 Hex-5-ynoic acid (1.68 g, 15 mmol) was dissolved in thionyl chloride (3.0 ml). The solution was heated at reflux for 2 hrs before all the solvent was removed under reduced pressure. The desired residue was added slowly into the solution of salicylic acid (1.0 g, 7.24 mmol) in pyridine (20 ml) at 0 o C. The mixture was stirred for 30 min at the same temperature and then quenched with ice. EA (200 ml) and HCl aqueous solution (1 N, 100 ml) were added to reaction mixture. The organics was taken, washed further with HCl aqueous solution (1 N, 100 ml×2) and brine (100 ml), 173.4, 172.1, 164.1, 70.4, 70.16, 70.14, 70.11, 70.06, 69.9, 69.74, 69.73, 67.2, 61.7, 60.0, 55.5, 53.3, 50.0, 45.5, 40.2, 38.9, 36.7, 36.5, 28.1, 27.8, 26.8, 25.4, 25.2, 8.51 .
To the solution of dichlorodiphenylsilane (0.60 ml, 2.70 mmol) and TEA (740 mg, 7.32 mmol) in anhydrous DCM (50 ml) was added Biotin-PEG-OH (300 mg, 0.54 mmol). After 10 h, 6-azidohexanol (900 mg, 6.6 mmol) was added. The reaction mixture was stirred at room temperature overnight before being loaded to silica gel column and then eluted with (DCM/MeOH = 10/1). 163.7, 134.7, 134.6 (m, 6C), 130.1, 127.8, 127.6 (m, 2C), 75.6, 70.4, 70.36, 70.33, 70.2, 70.0, 69.9, 67.2, 62.9, 61.7, 60.1, 55.4, 51.3, 50.3, 45.8, 40.4, 39.1, 37.0, 35.8, 32.1, 28.7, 28.1, 28.0, 27.5, 26.3, 25.5, 25.3 
Biochemical experiments

Reagents and antibodies
Besides the chemicals synthesized in the synthesis section, other reagents used in our experiments are listed below. Aspirin (99%), streptavidin beads, acetonitrile ( 
Cell culture
HCT116 and MEFs cell lines were purchased from ATCC (Manassas, VA). Both cell lines were cultured in Dulbecco's Modified Eagle Medium (Sigma Aldrich)
supplemented with 10% fetal bovine serum (Invitrogen) and 1 × antibiotic/antimycotic (Invitrogen). Cells were maintained at 37 in a humidified incubator supplemented with 5% CO 2 .
2.3
In situ fluorescence labeling using Asp-1/2 and Acetyl-P and competition assay HCT116 cells were grown to 80-90% confluence in 6-well plates. After the media was removed, cells were washed twice with PBS. Asp-P1/P2 or Acetyl-P (1000 μM) in 2 ml medium (1% DMSO) were added, and cells were incubated for 12 hrs at 37 °C and 5% CO 2 . An equal volume of DMSO was also used as a negative control. Cy3-azide (20 μM), TCEP (1 mM, 100 × fresh stock in water), TBTA ligand (100 μM, 100 × stock in DMSO), and CuSO 4 (1 mM, 100 × stock in water) were added to the lysate. The samples were incubated at room temperature for 2 hrs. Next, clicked proteins were precipitated by acetone and air dried. 1× SDS loading buffer (100 μl) was added to dissolve the sample, and 50 μl of sample was separated by SDS-PAGE on 12.5% polyacrylamide gel. After SDS-PAGE, gels were visualized using a Typhoon 9410 laser scanner (GE Healthcare; Buckinghamshire, UK) and images were analyzed by TotalLab software. For competition assay, the HCT116 cell lysate were pretreated with aspirin (1 mM or 2mM) for two hrs. Then the lysate were incubated for another 12 hrs together with aspirin probes (500µM). Probe labeled proteomes were visualized by click conjugation to the Cy3-azide tag followed by SDS-gel separation and fluorescence scanning.
Using QA-ABPP to identify targets of aspirin-induced acetylation
Cell labeling
In the subsequent QA-ABPP study, two biological duplicate of Asp-1/2 treated and two DMSO treated samples were pulled down and digested in parallel. The two biological duplicate of Asp-1/2 treated samples were labeled with iTRAQ reagent and quantified by iTRAQ ratios against the DMSO control samples. Briefly, HCT116 cells were grown to 80-90% confluence in T75 flasks. Used medium was then aspirated and the cells were washed twice with PBS. Asp-1/2 (1000 μM) in 10 ml medium (1% DMSO) was added to the cells in the flasks and incubated for 12 hrs in the CO 2 incubator.
Culture medium containing 1% DMSO was used as negative control. Subsequently, Asp-1/2 and DMSO-containing media were removed before the cells were washed with PBS and detached with trypsin. The cell pellet was resuspended in PBS, washed and lysed by sonication in PBS. The cell lysates were clarified by centrifugation at 13,000 rpm for 30 min followed by Bradford assay. Equal amount (5 mg) of cell lysates (4 probe treated and 2 DMSO treated samples) were used for subsequent click chemistry to conjugate proteins with the DADPS tag separately. For each reaction, DADPS (20 μM), TCEP (1 mM, 100 × fresh stock in water), TBTA ligand (100 μM, 100 × stock in DMSO), and CuSO 4 (1 mM, 100 × stock in water) were added to the cell lysates and incubated at room temperature for 4 hrs. Next, clicked proteins were subjected to precipitation with acetone and air dried. Subsequently, the pellet was dissolved in 1 ml of 0.1% SDS in PBS and incubated with 50 μl of Streptavidin beads (Sigma-Aldrich) under gentle mixing for 2 hrs at room temperature.
On-beads digestion by trypsin
The beads were washed a total of 9 times; thrice with 1% SDS, followed by thrice with urea (6 M) and thrice with PBS. The extensively washed beads were re-suspended in 100 µl 25 mM triethylammonium bicarbonate (TEAB) and 2 µl TCEP (100 mM stock solution) was added. The beads were placed in a 65°C heat block for 60 min. Next, 1 µl MMTS (200 mM stock solution) was added, and the samples left in the dark and allowed to react for 15 min at room temperature. After reduction and alkylation, trypsin (12.5 ng/ µl) was added and incubated at 37°C
overnight. The digested peptides were separated from the beads using a filter-spin column (GE Healthcare). These digested peptides could be stored at -20 °C for several months pending iTRAQ labeling and mass spectrometry analysis.
On-beads treatment with formic acid to cleave the probe modified peptide
For the pull down sample using Asp-P2, the washed and filtered beads which bear the binding peptides were further washed three times using 25 mM TEAB to remove the digested unmodified peptides. The beads were then incubated with 5% formic acid for 2 hrs to cleave the acid cleavable biotin tag. The resulting cleaved probe modified peptides were separated from the beads using a filter-spin column and identified using LC-MS/MS.
iTRAQ Labeling of the peptides from on-beads digestion by trypsin
iTRAQ labeling was performed using iTRAQ Reagent kit (AB SCIEX; Foster City, CA) based on the vender's instruction manual with minor modifications. The two biological replicates of the negative control pull-down samples were labelled with iTRAQ reagent 113 and 114, respectively. Similarly, two biological replicate of digested pull-down samples by Asp-1/2 probes were labeled with reagent 117, 118 and 119, 121 respectively. Briefly, the on-beads digested peptides were dried and reconstituted with equal volume of dissolution buffer (0.5M TEAB). The peptides were then labeled with the respective iTRAQ reagents and incubated at room temperature for 2 hrs before all the samples were pooled together. The iTRAQ workflow is shown in Figure 1b in the main text.
Strong cation exchange (SCX) chromatography and C18 desalting of iTRAQ labeled samples
To remove interfering substances like SDS, isopropanol, dissolution buffer (TEAB), reducing agent (TCEP), alkylating agent (MMTS), calcium chloride and excess iTRAQ reagents etc., the pooled iTRAQ-labeled peptide sample was subjected to strong cation exchange chromatography (SCX) using the iTRAQ Method Development Kit (AB SCIEX). The bound peptides were eluted with 5 % ammonium hydroxide (NH 4 OH) in 30 % methanol. The eluate was desalted using a Sep-Pak C 18 cartridge (Waters, Milford, MA), dried and then reconstituted with 100 μl of diluent (98% water, 2% acetonitrile (ACN), 0.05% formic acid (FA)).
Protein identification, quantification and Asp binding sites mapping
Nano LC−ESI-MS
The detailed methods for LC-MS/MS was described previously. (resolution >15000) with "adjust CE when using iTRAQ Reagent" on.
ProteinPilot
TM analysis
The detailed method of ProteinPilot TM analysis was described previously. Redundancy was eliminated by the grouping of identified proteins using the ProGroup algorithm in the software. A decoy database search strategy was used to determine the false discovery rate (FDR) for protein identification. A corresponding randomized database was generated using the Proteomics System Performance Evaluation Pipeline feature in the ProteinPilot™ Software 4.5. In this study, a stringent cut-off threshold with total unused score >1.3 was adopted as the qualification criterion, which corresponded to a protein confidence level of >95% and a false discovery rate (FDR) of 0.33%.
Quantitative iTRAQ data analysis
iTRAQ ratio for each protein was calculated using unique peptides identified only, excluding peptides with miscleavage and peptides missing an iTRAQ reagent label.
To reduce the likelihood of selecting the false-positive drug targets, we chose a stringent iTRAQ ratio equivalent to 2 as the cut-off threshold to identify specific protein targets for subsequent experiments. Moreover, the targets must be identified in both Asp-P1/P2 pull down results. Using these criteria, 1110 proteins were identified.
The full list of the 1110 potential targets is shown in Supplematary Table 2 .
Pathway analysis of aspirin targets
The specific aspirin targets-identified using the QA-ABPP approach-were analyzed using the Ingenuity Pathway Analysis software (IPA; Ingenuity® Systems, Redwood city, CA). A spreadsheet containing the list of aspirin targets was uploaded into IPA. The software mapped each of the proteins to the repository of information in the Ingenuity Pathways Knowledge base. Molecular networks and canonical pathways regulated by these drug targets were obtained using IPA core analysis.
Metabolic labeling of newly synthesized proteins with AHA
The cells with 70~80% confluency in a 6-well plate were washed with warm PBS and 
Estimation of intralysosomal pH using LysoTracker
The intralysosomal pH was estimated using LysoTracker, following manufacturer's instructions. The fluorescence intensity was observed under a confocal microscope (Olympus Fluoview FV1000) and representative cells were selected and photographed.
Western blotting
At the end of the designated treatments, cells were lysed in Laemmli SDS buffer (62.5 mM Tris, pH 6.8, 25% glycerol, 2% SDS, phosphatase inhibitor and proteinase inhibitor cocktails). An equal amount of protein was resolved by SDS-PAGE and transferred onto PVDF membrane. After blocking with 5% non-fat milk, the membrane was probed with designated primary and secondary antibodies, developed with the enhanced chemiluminescence method and visualized with ImageQuant LAS 
Cellular imaging of aspirin-induced acetylation
